Perspectivas 2026 de Amorepacific Group (KOSPI 002790) para el inversor extranjero. Diferencia entre la holding y la operadora 090430, el desapalancamiento en China y duty-free, el reequilibrio hacia EE.UU. y Japon, la compra de Cosrx, el valor de marca de Sulwhasoo y Laneige, y el descuento NAV.
Amorepacific Group (KOSPI 002790) 2026 outlook for foreign investors. How the holding company differs from operating co 090430, the China and duty-free deleveraging, the US and Japan rebalancing, the Cosrx acquisition, Sulwhasoo and Laneige brand equity, and the NAV discount debate.
Análisis de VT Cosmetics (KOSDAQ 018290) 2026: fuerza de marca de Reedle Shot, crecimiento explosivo de exportaciones indie-beauty a Japón y Amazon, canal Olive Young, dependencia de un solo producto estrella, riesgo de tendencias y el negocio de entretenimiento, desde la óptica del inversor global.
VT Cosmetics (KOSDAQ 018290) 2026 stock analysis: Reedle Shot brand strength, explosive Japan and Amazon indie-beauty export growth, Olive Young channel, single-hit-product dependence, cosmetics trend risk, and the entertainment segment — from a global investor's view.
Aekyung Industrial (KOSPI: 018250) 2026 stock analysis for global investors: the AGE 20's cosmetics franchise reducing its China export dependence and rebranding, the Kerasys, 2080, and Trio household-goods cash cow, domestic consumption, raw-material and currency exposure, LINE Friends and IP collaborations, the beauty-segment rebound scenario, and Aekyung Group risk.
Cosmecca Korea (KOSDAQ: 241710) 2026 stock analysis: the cosmetics ODM/OEM manufacturing engine behind the K-beauty and indie-brand export boom, the strategic value of US subsidiary Englewood Lab and its onshore American production, the split US-China-Korea manufacturing base, customer diversification, and the input-cost, FX, and tariff variables that drive margins — analyzed qualitatively for global investors.